The Experts below are selected from a list of 249 Experts worldwide ranked by ideXlab platform

J. F. Lonneux - One of the best experts on this subject based on the ideXlab platform.

  • field efficacy of injectable doramectin against Chorioptes bovis in naturally infected cattle
    Veterinary Record, 1998
    Co-Authors: Bertrand Losson, Bernard Mignon, K Bossaert, T Leclipteux, J. F. Lonneux
    Abstract:

    A single subcutaneous injection of doramectin at a dose rate of 200 micrograms/kg bodyweight was effective in controlling an infection of Chorioptes bovis mites in naturally infected cattle. From 14 days after treatment, the geometric mean number of live mites was significantly lower (P < 0.001) in the doramectin-treated cattle than in the control group at each sampling until day 35. The percentage efficacy (treated versus controls) of doramectin against C bovis at day 35 was 99.9 per cent and the percentage reduction (day 35 versus day 0) in the treated animals was 99.3 per cent. At day 35, all seven controls were still positive for C bovis whereas five of the eight doramectin-treated animals were free of live mites.

  • field efficacy of moxidectin 0 5 pour on against Chorioptes bovis damalinia bovis linognathus vituli and psoroptes ovis in naturally infected cattle
    Veterinary Parasitology, 1996
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoroptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days -4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group I), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg-1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days -3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg-1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg-1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that at a dose of 0.5 mg kg-1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis.

  • Field Efficacy of Moxidectin 0.5% Pour-on against Chorioptes Bovis, Damalinia Bovis, Linognathus Vituli and Psoroptes Ovis in Naturally Infected Cattle
    Veterinary parasitology, 1996
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Abstract Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoreptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg−1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days −4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg−1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group 1), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg−1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days −3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg−1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg−1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that a dose of 0.5 mg kg−1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis.

  • field efficacy of injectable moxidectin in cattle naturally infested with Chorioptes bovis and sarcoptes scabiei
    Veterinary Parasitology, 1993
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Abstract Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four animals each, based on parasitological and clinical status. Animals of the treated group received one subcutaneous injection of injectable moxidectin at 0.2 mg kg−1 body weight on Day 0. Individuals of the control group received emergency treatment of a single injection of moxidectin at 0.2 mg kg−1 body weight on Day 28. Efficacy was assessed by (a) taking skin samples from each animal on Days 0, 7, 14, 21, 28, 42 and 56 and observing the numbers of viable mite stages and species and (b) clinical examination of animals on Days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days 0, 28 and 56. On the basis of the geometric means from treated and control animals, the percentage reductions in the total numbers of living C. bovis mites on Days 7, 14, 21, and 28 were 69, 87, more than 99 and 98, respectively. However, at the end of the trial, only two animals were negative for C. bovis. The percentage reductions in the total numbers of S. scabiei on Days 7, 14, 21 and 28 were 93, 100, 100 and 100, respectively. Clinical indices of the treated animals showed a sharp decrease in the affected body surface area from mean of 43.6% on Day 0 to 0.9% and 0% on Days 28 and 56, respectively. The clinical condition of the controls worsened rapidly during the experiment (mean clinical index 37.5% and 81.6% on Days 0 and 28, respectively). All control animals were positive for both parasites on Day 28, when they were given an emergency treatment. Mean daily weight gains (DWG) were recorded in both groups; mean DWG values were extremely low in control animals (248 g day−1 vs. 723 day−1 in treated animals). Treatment of the controls on Day 28 was associated with a sharp increase of mean DWG (1431 g day−1). No local or general side effects were observed.

Set Bornstein - One of the best experts on this subject based on the ideXlab platform.

  • Chorioptes mites re evaluation of species integrity
    Medical and Veterinary Entomology, 2011
    Co-Authors: Jacqueline Lusat, Set Bornstein, Richard Wall
    Abstract:

    Chorioptes mites (Acari: Psoroptidae) are non-burrowing agents of mange which parasitize a wide range of domesticated and wild ungulates. Considerable historical confusion has surrounded the description and naming of the various species of Chorioptes. Here, the opisthosomal setae of male adult Chorioptes mites from a range of host species and geographic locations were subjected to detailed analysis. Discriminant analysis suggests the existence of three clear morphotypes. The first, Chorioptes bovis, is characterized by a very long seta 1 (ae) and short spatulate setae 2 (l4 and d5), whereas, in the second, Chorioptes texanus, setae 2 (l4 and d5) are longer and narrower than in C. bovis, but most of the other setae are shorter; this is particularly true for seta 1 (ae). A third morphotype is characterized by a seta 1 (ae) that is shorter than in C. bovis but longer than in C. texanus, long setae 2 (l4 and d5) and a long seta 6 (l5). The data are compared with previously published measurements. Although this analysis supports the validity of C. bovis and C. texanus as morphologically distinct, it also supports the existence of a proposed third species of Chorioptes, as described by Hestvik et al. in 2007, and suggests that the mites described by Sweatman in his classic 1958 description of C. texanus, which were obtained from the ears of semi-domesticated reindeer, are likely to have been specimens of this as yet unnamed species. The results show that there is a high degree of phenotypic plasticity in setal lengths. It is concluded that a statistical difference in the absolute measurement of any one seta is not a reliable species indicator; the relative sizes of groups of setae would appear to be more taxonomically informative and should be used when identifying Chorioptes morphologically.

  • Some important Ectoparasites of Alpaca (Vicugna pacos) and Llama (Lama glama)
    2010
    Co-Authors: Set Bornstein, Kerstin De Verdier²
    Abstract:

    Abstract The most important ectoparasites infesting/infecting alpaca (Vicugna pacos) and llama (Lama glama) are reviewed. The clinical manifestation and the diagnosis of the different parasitic infections/infestations of Sarcoptes scabiei, Chorioptes sp., Psoroptes sp., Damalinia (Bovicola) breviceps and Microthoracius spp. are described as well as therapies against them. Demonstrating S. scabiei and Chorioptes sp. with available diagnostic methods are challengingly often due to the relatively small numbers of mites that may elicit clinical disease. In Chorioptes sp. infestations it has been shown that alpacas are often subclinically infested. Predilection places are between the toes and in the axillae. The variable response to modern acaricidal treatments emphazises the need of more evidence based studies. The lack of lanolin in the fibres of South American camelids may explain the poor response to topical applications of modern insecticidal/acaricidal products used on other animals. Pharmacokinetic studies of such substances are limited. Few products are licenced although several products that are used and are available for other animals are used off-label. Applying a combination of systemic and topical treatments may produce optimal results. The need to apply treatments against the mange mites more frequently and with higher dosages of some of the acaricidal substances than recommended for other livestock is indicated. Lice infestations are often easier to deal with. Systemic treatment should be applied against suckling lice and topical against the biting lice. All animals in affected herds should be treated at the same time and stringent biosecurity measures following treatment is recommended to avoid re-infections/infestations

  • a previously unidentified Chorioptes species infesting outer ear canals of moose alces alces characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Monika Zahlerrinder, Dolores Gavierwiden, Roland Mattsson, David A Morrison, R. Lindberg, Set Bornstein
    Abstract:

    Background During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose (Alces alces) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described.

  • a previously unidentified Chorioptes species infesting outer ear canals of moose alces alces characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Monika Zahlerrinder, Dolores Gavierwiden, Roland Mattsson, David A Morrison, R. Lindberg, Set Bornstein
    Abstract:

    During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose (Alces alces) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described. External auditory meatuses from 53 necropsied moose were examined for the presence of Chorioptes, and samples from outer ear canals were taken for histopathological and microbiological examination. A proportion of the mites from each moose was identified to species. The DNA was extracted from mites from three moose, and their ITS-2 sequences were determined; these sequences were compared phylogenetically to sequences from other Chorioptes taxa. Chorioptes mites were found in 43 (81%) of the 53 moose. The mites had morphological and genetic characteristics distinct from those of C. texanus and C. bovis, the two species generally accepted within the genus. Morphology also did not argue for a diagnosis as C. crewei, C. mydaus or C. panda. On histopathology, lesions were characterized by a hyperplastic perivascular to interstitial dermatitis with epidermal hyperkeratosis and crust formation. Dermal inflammatory infiltrates were composed of mixed T- and B-lymphocytes, plasma cells and macrophages, whereas eosinophils were notably uncommon. Staphylococcus aureus was grown from the infested epidermis of five of 14 examined moose. Chorioptes mite infestation was frequently detected in the outer ear canals of moose in Sweden. The mites were evidently pathogenic, being associated with inflammatory lesions of the external auditory meatus. Our studies indicate infestations with a previously undescribed Chorioptes species.

  • A previously unidentified Chorioptes species infesting outer ear canals of moose (Alces alces): characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Roland Mattsson, R. Lindberg, Monika Zahler-rinder, Dolores Gavier-widén, David Morrison, Set Bornstein
    Abstract:

    Background During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose ( Alces alces ) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described. Methods External auditory meatuses from 53 necropsied moose were examined for the presence of Chorioptes , and samples from outer ear canals were taken for histopathological and microbiological examination. A proportion of the mites from each moose was identified to species. The DNA was extracted from mites from three moose, and their ITS-2 sequences were determined; these sequences were compared phylogenetically to sequences from other Chorioptes taxa. Results Chorioptes mites were found in 43 (81%) of the 53 moose. The mites had morphological and genetic characteristics distinct from those of C. texanus and C. bovis , the two species generally accepted within the genus. Morphology also did not argue for a diagnosis as C. crewei , C. mydaus or C. panda . On histopathology, lesions were characterized by a hyperplastic perivascular to interstitial dermatitis with epidermal hyperkeratosis and crust formation. Dermal inflammatory infiltrates were composed of mixed T- and B-lymphocytes, plasma cells and macrophages, whereas eosinophils were notably uncommon. Staphylococcus aureus was grown from the infested epidermis of five of 14 examined moose. Conclusion Chorioptes mite infestation was frequently detected in the outer ear canals of moose in Sweden. The mites were evidently pathogenic, being associated with inflammatory lesions of the external auditory meatus. Our studies indicate infestations with a previously undescribed Chorioptes species.

Bertrand Losson - One of the best experts on this subject based on the ideXlab platform.

  • field efficacy of injectable doramectin against Chorioptes bovis in naturally infected cattle
    Veterinary Record, 1998
    Co-Authors: Bertrand Losson, Bernard Mignon, K Bossaert, T Leclipteux, J. F. Lonneux
    Abstract:

    A single subcutaneous injection of doramectin at a dose rate of 200 micrograms/kg bodyweight was effective in controlling an infection of Chorioptes bovis mites in naturally infected cattle. From 14 days after treatment, the geometric mean number of live mites was significantly lower (P < 0.001) in the doramectin-treated cattle than in the control group at each sampling until day 35. The percentage efficacy (treated versus controls) of doramectin against C bovis at day 35 was 99.9 per cent and the percentage reduction (day 35 versus day 0) in the treated animals was 99.3 per cent. At day 35, all seven controls were still positive for C bovis whereas five of the eight doramectin-treated animals were free of live mites.

  • field efficacy of moxidectin 0 5 pour on against Chorioptes bovis damalinia bovis linognathus vituli and psoroptes ovis in naturally infected cattle
    Veterinary Parasitology, 1996
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoroptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days -4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group I), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg-1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days -3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg-1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg-1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that at a dose of 0.5 mg kg-1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis.

  • Field Efficacy of Moxidectin 0.5% Pour-on against Chorioptes Bovis, Damalinia Bovis, Linognathus Vituli and Psoroptes Ovis in Naturally Infected Cattle
    Veterinary parasitology, 1996
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Abstract Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoreptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg−1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days −4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg−1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group 1), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg−1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days −3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg−1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg−1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that a dose of 0.5 mg kg−1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis.

  • field efficacy of injectable moxidectin in cattle naturally infested with Chorioptes bovis and sarcoptes scabiei
    Veterinary Parasitology, 1993
    Co-Authors: Bertrand Losson, J. F. Lonneux
    Abstract:

    Abstract Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four animals each, based on parasitological and clinical status. Animals of the treated group received one subcutaneous injection of injectable moxidectin at 0.2 mg kg−1 body weight on Day 0. Individuals of the control group received emergency treatment of a single injection of moxidectin at 0.2 mg kg−1 body weight on Day 28. Efficacy was assessed by (a) taking skin samples from each animal on Days 0, 7, 14, 21, 28, 42 and 56 and observing the numbers of viable mite stages and species and (b) clinical examination of animals on Days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days 0, 28 and 56. On the basis of the geometric means from treated and control animals, the percentage reductions in the total numbers of living C. bovis mites on Days 7, 14, 21, and 28 were 69, 87, more than 99 and 98, respectively. However, at the end of the trial, only two animals were negative for C. bovis. The percentage reductions in the total numbers of S. scabiei on Days 7, 14, 21 and 28 were 93, 100, 100 and 100, respectively. Clinical indices of the treated animals showed a sharp decrease in the affected body surface area from mean of 43.6% on Day 0 to 0.9% and 0% on Days 28 and 56, respectively. The clinical condition of the controls worsened rapidly during the experiment (mean clinical index 37.5% and 81.6% on Days 0 and 28, respectively). All control animals were positive for both parasites on Day 28, when they were given an emergency treatment. Mean daily weight gains (DWG) were recorded in both groups; mean DWG values were extremely low in control animals (248 g day−1 vs. 723 day−1 in treated animals). Treatment of the controls on Day 28 was associated with a sharp increase of mean DWG (1431 g day−1). No local or general side effects were observed.

Gete Hestvik - One of the best experts on this subject based on the ideXlab platform.

  • Integrated Bayesian species delimitation and morphological diagnostics of chorioptic mange mites (Acariformes: Psoroptidae: Chorioptes)
    Parasitology Research, 2014
    Co-Authors: Andre V. Bochkov, Gete Hestvik, Pavel B. Klimov, Alexander P. Saveljev
    Abstract:

    The external morphology of adult and immature stages of mange mites of the genus Chorioptes was investigated with the aid of light and scanning electron microscopy. A molecular phylogeny of this genus was inferred based on six genes (18S, 28S rDNA, EF1-α, SRP54, HSP70, and CO1). The validity of four species ( Ch. bovis , Ch. panda , Ch. texanus , and Ch. sweatmani sp. nov. described from the moose from Sweden, Finland, and Russia) was confirmed based on morphology and a Bayesian species delimitation analysis incorporating both gene tree uncertainties and incomplete lineage sorting via the coalescent process model in BPP. Sequence data for Ch. crewei and Ch. mydaus was not available but their morphology strongly suggests their validity. The six valid Chorioptes species are diagnosed using type and non-type specimens, and a key to species is provided. Ch. sweatmani differs from closely related Ch. texanus by the following features: in males, the body length, including the gnathosoma, is 380–405 μm (vs. 220–295 in Ch. texanus ), the idiosoma is 3–4 times longer than setae cp (vs. 1.3-1.6 times longer), legs III are approximately three times longer than setae sR III (vs. 1.8–2 times longer), the apical spur of tarsus III is curved (vs. straight), a spur near seta f III base is not developed (vs. small but distinct); in females, setae h2 are 1.4–1.5 times shorter than legs IV (vs. about two times longer). Hosts and distribution records of Chorioptes species are summarized.

  • a previously unidentified Chorioptes species infesting outer ear canals of moose alces alces characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Monika Zahlerrinder, Dolores Gavierwiden, Roland Mattsson, David A Morrison, R. Lindberg, Set Bornstein
    Abstract:

    Background During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose (Alces alces) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described.

  • a previously unidentified Chorioptes species infesting outer ear canals of moose alces alces characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Monika Zahlerrinder, Dolores Gavierwiden, Roland Mattsson, David A Morrison, R. Lindberg, Set Bornstein
    Abstract:

    During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose (Alces alces) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described. External auditory meatuses from 53 necropsied moose were examined for the presence of Chorioptes, and samples from outer ear canals were taken for histopathological and microbiological examination. A proportion of the mites from each moose was identified to species. The DNA was extracted from mites from three moose, and their ITS-2 sequences were determined; these sequences were compared phylogenetically to sequences from other Chorioptes taxa. Chorioptes mites were found in 43 (81%) of the 53 moose. The mites had morphological and genetic characteristics distinct from those of C. texanus and C. bovis, the two species generally accepted within the genus. Morphology also did not argue for a diagnosis as C. crewei, C. mydaus or C. panda. On histopathology, lesions were characterized by a hyperplastic perivascular to interstitial dermatitis with epidermal hyperkeratosis and crust formation. Dermal inflammatory infiltrates were composed of mixed T- and B-lymphocytes, plasma cells and macrophages, whereas eosinophils were notably uncommon. Staphylococcus aureus was grown from the infested epidermis of five of 14 examined moose. Chorioptes mite infestation was frequently detected in the outer ear canals of moose in Sweden. The mites were evidently pathogenic, being associated with inflammatory lesions of the external auditory meatus. Our studies indicate infestations with a previously undescribed Chorioptes species.

  • A previously unidentified Chorioptes species infesting outer ear canals of moose (Alces alces): characterization of the mite and the pathology of infestation
    Acta Veterinaria Scandinavica, 2007
    Co-Authors: Gete Hestvik, Roland Mattsson, R. Lindberg, Monika Zahler-rinder, Dolores Gavier-widén, David Morrison, Set Bornstein
    Abstract:

    Background During the past decade, Chorioptes mites occupying the outer ear canals have been a common finding at routine necropsies of moose ( Alces alces ) in Sweden, but neither the taxonomy of the mites nor lesions from the infestation have been investigated. In this study, the mites are characterized by morphological and molecular techniques, and the histopathology of the skin of the outer ear canal is described. Methods External auditory meatuses from 53 necropsied moose were examined for the presence of Chorioptes , and samples from outer ear canals were taken for histopathological and microbiological examination. A proportion of the mites from each moose was identified to species. The DNA was extracted from mites from three moose, and their ITS-2 sequences were determined; these sequences were compared phylogenetically to sequences from other Chorioptes taxa. Results Chorioptes mites were found in 43 (81%) of the 53 moose. The mites had morphological and genetic characteristics distinct from those of C. texanus and C. bovis , the two species generally accepted within the genus. Morphology also did not argue for a diagnosis as C. crewei , C. mydaus or C. panda . On histopathology, lesions were characterized by a hyperplastic perivascular to interstitial dermatitis with epidermal hyperkeratosis and crust formation. Dermal inflammatory infiltrates were composed of mixed T- and B-lymphocytes, plasma cells and macrophages, whereas eosinophils were notably uncommon. Staphylococcus aureus was grown from the infested epidermis of five of 14 examined moose. Conclusion Chorioptes mite infestation was frequently detected in the outer ear canals of moose in Sweden. The mites were evidently pathogenic, being associated with inflammatory lesions of the external auditory meatus. Our studies indicate infestations with a previously undescribed Chorioptes species.

Lonneux J. F. - One of the best experts on this subject based on the ideXlab platform.

  • Field Efficacy of Injectable Doramectin against Chorioptes Bovis in Naturally Infected Cattle
    1998
    Co-Authors: Losson Bertrand, Mignon Bernard, Bossaert K., Leclipteux T., Lonneux J. F.
    Abstract:

    A single subcutaneous injection of doramectin at a dose rate of 200 micrograms/kg bodyweight was effective in controlling an infection of Chorioptes bovis mites in naturally infected cattle. From 14 days after treatment, the geometric mean number of live mites was significantly lower (P < 0.001) in the doramectin-treated cattle than in the control group at each sampling until day 35. The percentage efficacy (treated versus controls) of doramectin against C bovis at day 35 was 99.9 per cent and the percentage reduction (day 35 versus day 0) in the treated animals was 99.3 per cent. At day 35, all seven controls were still positive for C bovis whereas five of the eight doramectin-treated animals were free of live mites.Peer reviewe

  • Field Efficacy of Moxidectin 0.5% Pour-on against Chorioptes Bovis, Damalinia Bovis, Linognathus Vituli and Psoroptes Ovis in Naturally Infected Cattle
    1996
    Co-Authors: Losson Bertrand, Lonneux J. F.
    Abstract:

    Field efficacy of a pour-on formulation of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis, Damalinia bovis, Linognathus vituli and Psoroptes ovis. In trial 1, two experimental groups of cattle naturally infested with P. ovis were formed. Group 1 animals remained as untreated controls whereas Group 2 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by (a) taking skin samples from each animal on days -4, 7, 14, 21, 28, 42 and 56 post treatment (PT) and observing the numbers of viable P. ovis mites and (b) clinical examination of animals on days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated and live body weights recorded for each animal on days 4, 28 and 42. The pour-on formulation of moxidectin yielded excellent efficacy as no live mites were found in treated animals at 14, 21, 28, 42 and 56 days PT, except in one animal from which one adult mite was collected on day 42. Clinical indices showed a regular decrease in the affected body surface area. All untreated animals but one remained positive until day 28 and their clinical condition worsened rapidly. In trial 2, two experimental groups of cattle naturally infested with D. bovis and L. vituli were selected. Group 1 remained as untreated controls whereas Group 2 individuals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.5 mg kg-1 bw. Efficacy was assessed by identifying and counting lice on eight 15 cm hair partings at predefined anatomical sites on days 0, 14, 28 and 42. On the basis of animals cured and lice count reduction, efficacies were 100% on day 14 and from then onwards for both species. In trial 3, 24 animals naturally infested with C. bovis were divided into three experimental groups comprising eight (Group I), seven (Group 2) and nine animals (Group 3). Group 1 was the untreated control group whereas Groups 2 and 3 animals were treated on day 0 with 0.5% moxidectin cattle pour-on at a dose of 0.25 mg and 0.5 mg kg-1 bw, respectively. Efficacy was assessed as in trial 1. Skin scrapings were collected on days -3, 7, 14, 28, 42 and 56 PT. A clinical index was calculated for each animal on days 0, 28 and 56 whereas body weights were recorded on days 0 and 56. At 0.25 mg kg-1 bw, the efficacy of moxidectin cattle pour-on against C. bovis was incomplete. In contrast, at a dose of 0.5 mg kg-1 bw, moxidectin cattle pour-on was fully effective and by day 14 PT all animals were negative for C. bovis and remained so until the end of the trial. No side effects were observed during these three trials. These results indicate that at a dose of 0.5 mg kg-1 bw, the pour-on formulation of moxidectin is highly effective against C. bovis, D. bovis, L. vituli and P. ovis.Peer reviewe

  • Field Efficacy of Injectable Moxidectin in Cattle Naturally Infested with Chorioptes Bovis and Sarcoptes Scabiei
    1993
    Co-Authors: Losson Bertrand, Lonneux J. F.
    Abstract:

    Field efficacy of moxidectin, a macrocyclic lactone endectocide, was evaluated in cattle naturally infested with Chorioptes bovis and Sarcoptes scabiei. Eight animals were allocated to two groups of four animals each, based on parasitological and clinical status. Animals of the treated group received one subcutaneous injection of injectable moxidectin at 0.2 mg kg-1 body weight on Day 0. Individuals of the control group received emergency treatment of a single injection of moxidectin at 0.2 mg kg-1 body weight on Day 28. Efficacy was assessed by (a) taking skin samples from each animal on Days 0, 7, 14, 21, 28, 42 and 56 and observing the numbers of viable mite stages and species and (b) clinical examination of animals on Days 7, 14, 21, 28, 42 and 56 with the percentage of affected body surface calculated for each animal on Days 0, 28 and 56. On the basis of the geometric means from treated and control animals, the percentage reductions in the total numbers of living C. bovis mites on Days 7, 14, 21 and 28 were 69, 87, more than 99 and 98, respectively. However, at the end of the trial, only two animals were negative for C. bovis. The percentage reductions in the total numbers of S. scabiei on Days 7, 14, 21 and 28 were 93, 100, 100 and 100, respectively. Clinical indices of the treated animals showed a sharp decrease in the affected body surface area from a mean of 43.6% on Day 0 to 0.9% and 0% on Days 28 and 56, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)Peer reviewe